These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11852822)
1. [Methotrexate--mechanism of action and application]. Dabkowska B; Dabkowski J Pol Merkur Lekarski; 2001 Nov; 11(65):452-5. PubMed ID: 11852822 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate therapy. Schep GN Can J Gastroenterol; 1998; 12(1):26-7. PubMed ID: 9544409 [TBL] [Abstract][Full Text] [Related]
3. Effect of methotrexate and folinic acid on skeletal growth in mice. Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate inhibits the glyoxalase system in vivo in children with acute lymphoid leukaemia. Bartyik K; Turi S; Orosz F; Karg E Eur J Cancer; 2004 Oct; 40(15):2287-92. PubMed ID: 15454255 [TBL] [Abstract][Full Text] [Related]
5. [Methotrexate]. Schröder F; Schroeder JO Dtsch Med Wochenschr; 2000 Nov; 125(47):1435-6. PubMed ID: 11130122 [No Abstract] [Full Text] [Related]
6. Leflunomide. Cannon GW; Kremer JM Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636 [TBL] [Abstract][Full Text] [Related]
9. [Methotrexate in dermatology: pharmacology, indications, applications and prudent use]. Lebrun-Vignes B; Bachelez H; Chosidow O Rev Med Interne; 1999 Aug; 20 Suppl 3():384s-392s. PubMed ID: 10480190 [TBL] [Abstract][Full Text] [Related]
10. The use of methotrexate in dermatology: a review. Shen S; O'Brien T; Yap LM; Prince HM; McCormack CJ Australas J Dermatol; 2012 Feb; 53(1):1-18. PubMed ID: 22309324 [TBL] [Abstract][Full Text] [Related]
11. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Tian H; Cronstein BN Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664 [TBL] [Abstract][Full Text] [Related]
12. The use of systemic immune moderators in dermatology: an update. Kazlow Stern D; Tripp JM; Ho VC; Lebwohl M Dermatol Clin; 2005 Apr; 23(2):259-300. PubMed ID: 15837155 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenomics of methrotexate: a strategy for a customized therapeutic scheme for patients with rheumatoid arthritis]. Mena-Ramírez JP; Salazar-Páramo M; Dávalos-Rodríguez IP Gac Med Mex; 2008; 144(5):449-51. PubMed ID: 19043967 [TBL] [Abstract][Full Text] [Related]
17. [Individual monitoring of thiopurine and methotrexate treatment]. Baslund B; Dalhoff KP; Schmiegelow K Ugeskr Laeger; 2005 May; 167(20):2177-9. PubMed ID: 15987078 [No Abstract] [Full Text] [Related]